AG Hilgers Joins FTC Lawsuit Against Hims and Hers for Deceptive and Unlawful Privacy Practices

Nebraska AG Mike Hilgers joined an FTC lawsuit against Hims & Hers, alleging deceptive privacy and billing practices. The complaint claims the company shared sensitive health data with advertisers and charged consumers before consultations. The case seeks injunctions, restitution, and penalties.

Original reporting
Published Nov 12, 2026, 6:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 7:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AG Hilgers Joins FTC Lawsuit Against Hims and Hers for Deceptive and Unlawful Privacy Practices — source image
Decision brief

The 30-second read

$HIMSBearishLow
01

Why it matters

Regulatory risk adds a downside catalyst for Hims & Hers and may influence investor sentiment across the telehealth space.

02

Market read

The lawsuit introduces new regulatory risk for Hims & Hers, likely prompting a short‑term price decline and heightened scrutiny of the telehealth sector.

03

What to watch

Potential for the case to prompt industry‑wide privacy reforms, creating long‑term compliance opportunities.

Relevance 7/10Novelty 7/10Timing: today

Background

The FTC and multiple states have coordinated a legal action targeting privacy and billing practices of a prominent telehealth provider.

Company-level read

Ticker impact

$HIMSBearishHigh confidence
Context

FTC and state lawsuit alleges Hims & Hers shared health data and charged for subscriptions without proper consent.

Expected impact

likely downward pressure as market prices in possible fines and reputational damage

Evidence & confidence

Enforcement actions against a health‑tech firm typically lead to short‑term share declines and heightened compliance costs.

Market effects

Telehealth sector may face increased regulatory scrutiny, affecting peers.

U.S. market may see modest sell‑off in health‑tech stocks.

Limited to U.S. listed health‑tech companies.

Counterpoint

If the lawsuit is settled quickly with minimal penalties, the impact could be muted.

Key entities

  • Nebraska Attorney General Mike Hilgers

    Co‑plaintiff in the FTC lawsuit.

  • Federal Trade Commission

    Lead federal agency filing the lawsuit.

Related articles

$LLYHigh

More Good News for Eli Lilly Sends the Stock Even Higher

Eli Lilly (NYSE:LLY) shares rose after positive phase 3 trial results for retatrutide in treating knee osteoarthritis pain and weight loss. The company also partnered with Hims & Hers to expand access to GLP-1 drugs. Additionally, Lilly reported that Foundayo reduced sleep apnea severity, with FDA submission planned. Q3 revenue grew 39% to $24.4B, and earnings per share increased 16% to $7.22. Jefferies raised its price target to $1,700.

$HIMSHigh

Which Dates Could Move Hims & Hers Stock Most?

Hims & Hers Health (HIMS) stock fell 30.0% in November 2026, underperforming the S&P 500. The company cut its 2026 adjusted EBITDA guidance to $267M, citing challenges in the U.K. and Germany. It faces a securities class action related to an FTC complaint. Key events include slower U.S. weight loss marketing and a push into international markets, with fiscal Q4 subscriber numbers being a focus.

$HIMSHigh

Five States Join FTC Suit Against Hims & Hers Over Privacy Practices

Five US states joined the FTC's lawsuit against Hims & Hers, alleging deceptive privacy practices, including sharing sensitive health data with Meta and Snap. The amended complaint also accuses the company of misleading billing and cancellation practices. Hims & Hers plans to defend itself, while the FTC claims the company charges users before provider consultations and complicates cancellations. The company recently cut its full-year profit forecast due to higher costs.

$HIMSMed

Hims & Hers Faces Widening FTC Lawsuit as Five States Join Privacy Case

Hims & Hers faces an expanded FTC lawsuit, with five states joining allegations of privacy violations and deceptive billing practices. The FTC claims the company shared sensitive health data with Meta and Snap, contradicting privacy assurances. Hims & Hers disputes the allegations, citing unfounded claims. The case highlights regulatory risks for digital healthcare providers.